Long Term Debt - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GlaxoSmithKline PLC
Long-Term Debt Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Long-Term Debt
ÂŁ13.6B
CAGR 3-Years
-13%
CAGR 5-Years
-10%
CAGR 10-Years
-1%
A
AstraZeneca PLC
NASDAQ:AZN
Long-Term Debt
$28.2B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
14%
Indivior PLC
LSE:INDV
Long-Term Debt
$268m
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Long-Term Debt
$1.1B
CAGR 3-Years
12%
CAGR 5-Years
59%
CAGR 10-Years
15%
Allergy Therapeutics PLC
LSE:AGY
Long-Term Debt
ÂŁ8.1m
CAGR 3-Years
-6%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Dechra Pharmaceuticals PLC
LSE:DPH
Long-Term Debt
ÂŁ500.6m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
17%

See Also

What is GlaxoSmithKline PLC's Long-Term Debt?
Long-Term Debt
13.6B GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Long-Term Debt amounts to 13.6B GBP.

What is GlaxoSmithKline PLC's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
-1%

Over the last year, the Long-Term Debt growth was -13%. The average annual Long-Term Debt growth rates for GlaxoSmithKline PLC have been -13% over the past three years , -10% over the past five years , and -1% over the past ten years .

Back to Top